Hemorrhage clinical trials

The registry lists 1,383 studies for Hemorrhage across more than 10 countries. 244 are recruiting or about to start. 547 of them are mainly about Hemorrhage (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09.

Get an email when these change. Save the Hemorrhage studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 770
Status unknown: 197
Recruiting: 169
Terminated: 77
Not yet recruiting: 61
Withdrawn: 52

Phase

Phase 4: 211
Phase 3: 185
Phase 2: 148
Phase 1: 49
Early Phase 1: 5

Where

United States: 354
France: 120
Canada: 107
China: 97
Italy: 69
United Kingdom: 64

Who runs them

Assiut University (12) · Cairo University (12) · Assistance Publique - Hôpitaux de Paris (12) · Hamilton Health Sciences Corporation (10) · Mayo Clinic (10) · Ethicon, Inc. (9) · Pfizer (9) · Boehringer Ingelheim (8)

What is being tested here

Drugs under test in Hemorrhage studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Tranexamic Acid	21	40	133
Rivaroxaban	6	5	19
Apixaban	6	4	10
Aspirin	4	3	14
Cenvacibart	4	2	5
Enoxaparin	3	2	12
Epinephrine	2	2	10
Heparin	2	2	9
Carbetocin	2	0	7
Deamino Arginine Vasopressin	2	1	7

Drug classes tested here Antifibrinolytics 21 open · Factor Xa inhibitors 10 open · NSAIDs 4 open · P2Y12 inhibitors 2 open · Local anesthetics 1 open

Coming up

40phase 3 studies under way

86studies finish main data collection within a year14 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Dec 2026Restarting Anticoagulation After Traumatic Intracranial Hemorrhage · Phase 3 · University of Texas at Austin
Dec 2026An Open-label Study of Intravenous Immunoglobulin (5%) for the Treatment of Primary Immune Thrombocytopenia · Phase 3 · Grand Shuyang Life Sciences (Chengdu) Co., Ltd.
Dec 2026A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery · Phase 3 · Corza Medical GmbH
Dec 2026Anticoagulation-free VV ECMO for Acute Respiratory Failure · Phase 3 · Damian Ratano
Jan 2027The Effects of Intraoperative Tranexamic Acid on Perioperative Bleeding In Craniotomies · Phase 3 · Stephen Lownie
Feb 2027Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial · Phase 3 · Hamilton Health Sciences Corporation
Apr 2027Rivaroxaban vs Warfarin in Patients With Mechanical Heart Valves · Phase 3 · Rawalpindi Institute of Cardiology
Apr 2027Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies · Phase 3 · Yale University
Jun 2027The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial · Phase 3 · Population Health Research Institute
Jun 2027Optimization Strategies for Blood Transfusion Protocols in the Emergency Treatment of Hemorrhagic Shock · Phase 3 · Xijing Hospital

Who these studies take

Of the 169 Hemorrhage studies recruiting now, 108 (64%) set no upper age limit and 40 (24%) stop at 75 or younger. 25 (15%) take children under 18. 19 (11%) are for women only and 4 (2%) for men only; 21 (12%) take healthy volunteers.

Recruiting studies that take each age, of 169
Age	Women	Men
10	14 (8%)	16 (9%)
18	143 (85%)	131 (78%)
30	154 (91%)	137 (81%)
40	154 (91%)	138 (82%)
50	147 (87%)	138 (82%)
65	141 (83%)	134 (79%)
75	136 (80%)	128 (76%)
85	119 (70%)	111 (66%)

Across all 1,383 studies, recruiting or not: 26% stop at 75 or younger and 19% at 65; 18% take children; 12% are for women only and 2% for men only; 19% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Hemorrhage studies take

Of 96 phase 4 interventional studies under Hemorrhage, half reached primary completion within 28 months of starting, counting those still running.

Start to primary completion	Every sponsor	Industry	Non-industry
Phase 1	27 mo6–42 · 17 studies	—	—
Phase 2	23 mo14–35 · 51 studies	—	25 mo14–39 · 43 studies
Phase 3	42 mo26–65 · 71 studies	—	42 mo26–72 · 45 studies
Phase 4	28 mo18–58 · 96 studies	—	28 mo18–58 · 92 studies
Interventional, no phase	19 mo9–35 · 226 studies	12 mo7–29 · 35 studies	19 mo10–37 · 191 studies
Observational	33 mo14–71 · 157 studies	—	37 mo15–78 · 133 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 1,383. Browse all 1,383 → or search them.